Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo

Targeted drug approaches have been a major focus for developing new anticancer therapies. Although many such agents approved in the last 20 years have improved outcomes, almost all have underperformed expectations. The full potential of such agents may yet be obtained through novel combinations. Pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Showalter, Loral, Czerniecki, Brian J., Koski, Gary K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392628/
https://www.ncbi.nlm.nih.gov/pubmed/32774769
http://dx.doi.org/10.18632/oncotarget.27556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392628/
https://www.ncbi.nlm.nih.gov/pubmed/32774769
http://dx.doi.org/10.18632/oncotarget.27556

Ejemplares similares